ISSN (Online): 1694-4674
  1. Home
  2. (2026)
  3. Diagnosis Does Not Differentiate Adherence: Sociodemographic Factors T…
Original Research Open Access

Diagnosis Does Not Differentiate Adherence: Sociodemographic Factors Take Precedence as the Primary Determinants of Medication Adherence in Diabetes, Hypertension and Comorbidity in Andaman & Nicobar Islands, India

, , ,
Annals of Medicine and Medical Sciences (2026) April 8, 2026 pp. 372 - 378
9 36
Download PDF

Abstract

Objective: This study aimed to evaluate medication adherence and its associated sociodemographic and clinical determinants among adults diagnosed with Diabetes and/or Hypertension in South Andaman. Methods: A cross-sectional study was conducted among 400 adults where medication adherence was assessed using the 10-item Medication Adherence Report Scale (MARS-10) and categorized into good (score>6) and poor adherence. Sociodemographic and clinical variables were also assessed and associations were analyzed using Chi-square test or Fisher’s exact test, as appropriate. Results: The mean medication adherence score was 7.74 (1.42), with 89.3% of participants (357/400) demonstrating good adherence. Item-level analysis of the MARS-10 indicated largely favourable medication beliefs, with most participants reporting clearer thoughts on medication (96.5%) and recognizing its role in preventing illness (95.8%). Intentional non-adherence was uncommon, though forgetting medication occasionally was reported by 35.0%. Negative medication perceptions were minimal. Adherence did not vary significantly across any sociodemographic or clinical characteristics examined (p > 0.05). Conclusion: Medication adherence among adults with Diabetes and/or Hypertension in South Andaman was high and appeared uniformly distributed across sociodemographic and clinical strata.

Keywords

Andaman and Nicobar Islands Diabetes Hypertension MARS-10 Medication adherence.

Introduction

Diabetes Mellitus and cardiovascular disease including Hypertension are among the most prevalent and impactful Non-Communicable Diseases (NCDs) worldwide, contributing substantially to global morbidity, mortality, and health system burden [1]. Globally, an estimated 830 million adults are living with Diabetes and prevalence continues to rise, with projections exceeding 853 million by 2050, while Hypertension remains a leading cause of cardiovascular morbidity and premature death across populations [2,3]. In India, the burden of these chronic conditions has increased markedly over recent decades, with Diabetes and Hypertension affecting an estimated 11.1% and 33% of adult population respectively, reflecting the rapid epidemiologic transition and growing lifestyle-related risk factors in the country [2,4]. Effective management of Diabetes and Hypertension requires long-term pharmacotherapy and lifestyle modification, yet optimal disease control is persistently undermined by poor medication adherence, which in turn is associated with increased complications, hospitalizations, and healthcare costs [5]. While medication adherence is central to chronic disease management, data from geographically distinct settings such as South Andaman remain scarce. The present study, therefore, aimed to assess medication adherence and its sociodemographic and clinical factors associated with it, among adults with Diabetes and/or Hypertension in South Andaman, thereby addressing a critical gap in the Indian evidence base for adherence research.

Methods

Study Design and Setting

A facility-based cross-sectional analytical study design was adopted to asses medication adherence among adults with Diabetes and/or Hypertension. Three health training centres from South Andaman- Rural Health Training Centre at Chouldhari, Urban Health Training Centre at Haddo and Community Health Centre at Bambooflat- affiliated with Department of Community Medicine of Andaman and Nicobar Islands Institute of Medical Sciences (ANIIMS) were selected as study setting.

Study population

Study was conducted among adults aged 18 years and above residing in South Andaman who had been diagnosed with Diabetes and/or Hypertension and were currently receiving treatment. Individuals who were critically ill, recently hospitalised (within the past one month), with known psychiatric comorbidities, with severe visual or hearing impairment or cognitive impairment were excluded from the study.

Sample size and Sampling

The sample size was calculated using the formula for estimating the sample size in a cross-sectional study n=z2p(1-p)/d2, assuming a 95% confidence level (z = 1.96), a prevalence of poor medication adherence of 39.5% as reported by Olickal et al. and an absolute precision of 5% [6]. Based on this calculation, the required minimum sample size was 368. The sample size was rounded up to 400 participants to accommodate for non-response. Participants were recruited consecutively for data collection from the three health centres.

Data collection and instrument

The questionnaire consisted of sociodemographic and selected clinical parameters of the participants and Medication Adherence Report Scale (MARS-10). MARS-10 is a validated self-reported questionnaire comprising 10 statements that capture both intentional and unintentional non-adherence behaviors in individuals with chronic illnesses. The tool employs a dichotomous Yes/No response format, generating a total score ranging from 0 to 10, with higher scores indicating better adherence. Participants were classified as adherent if they responded “No” to items 1-6 and 9-10 and “Yes” to items 7-8. In addition to the total score, individual item responses were examined to identify specific adherence barriers, including intentional non-adherence related to concerns such as side effects[7]. A score of >6 in total was considered as good adherence and less than that was taken as poor adherence as per the common criteria[8].

Study procedure

After explaining the purpose of the study, informed consent was obtained from each of the participants and data was collected via interview method. Trained data collectors enquired the questions in the language understandable to the participants and responses were recorded in Epicollect5. The study was completed in three months from the approval of Institutional Ethical Committee of ANIIMS.

Results

The study enrolled 400 participants, of whom 178 (44.5%) were male and 222 (55.5%) were female. The majority of participants were below 60 years of age (68.0%), with a slightly higher proportion of younger participants among females (70.7%) compared to males (64.6%). The mean age of participants was 56.57 (10.80) years with age ranging from 32 to 93 years. In terms of educational attainment, secondary education was the most common among males (43.3%), whereas a considerable proportion of females had no formal education (38.7%). Regarding occupation, most females were unemployed or retired (75.7%), while males were more occupationally diverse, with elementary occupations being the most common (22.5%). The predominant socioeconomic category across both sexes was Upper Lower category (as per modified Kuppuswamy classification), accounting for 49% of the total sample [9]. Hinduism was the most prevalent religion (73.0%), and the majority of participants belonged to the General category (77.3%). Nuclear families were the most common household type (52.2%), and most participants were married (88.8%), with widowhood being more frequent among males (79.1% of all widowed participants). Nearly all participants were native island residents (94.3%), with a slightly higher proportion of non-native residents among males (8.4%) than females (3.6%). The details of sociodemographic composition of the study sample is shown in Table I.

Among the 400 participants, 121 had Diabetes, 172 had Hypertension, and 107 had both the diseases. Table II describes the selected clinical parameters that were assessed. Participants indicated a considerable duration of chronic illness, with the average duration from diagnosis being similar for Diabetes (6.62 years) and Hypertension (6.66 years), suggesting prolonged exposure to both disorders. People with Diabetes took an average of 1.64 (0.73) drugs, while people with Hypertension took an average of 2.22 (1.50) medications. This suggests that managing Hypertension is relatively more complicated than managing Diabetes in this setting. Among the participants 262 were taking more than one drug (polytherapy) while the rest 138 were on a single medication. According to the Asian system of BMI classification, most of the people who took part (56%) are in the Obese group [10]. Participants reported an average sleep duration of 6.59 (1.34) hours per day, marginally below the recommended minimum of 7 hours [11].

The mean medication adherence score was 7.74 (1.42). The majority of participants demonstrated good adherence (score>5), with 357 individuals (89.3%) classified as adherent, while 43 participants (10.8%) were categorized as having poor adherence. Item-wise analysis of the MARS-10 components (as shown in Figure 1) indicated generally favourable adherence behaviour among participants. While 35.0% (140/400) reported occasionally forgetting to take their medication, substantially fewer participants admitted to being careless (17.8%) or stopping medication when feeling better (12.0%) or worse (3.8%). Nearly two-fifths (37.3%) reported taking medication only when sick. Negative perceptions regarding medication were relatively uncommon: 16.5% felt it was unnatural to be controlled by medication, 18.0% reported feeling tired or sluggish, and 0.5% reported feeling “like a zombie” on medication. In contrast, strong positive beliefs about medication were observed, with 96.5% agreeing that their thoughts are clearer on medication and 95.8% reporting that staying on medication prevents illness. Overall, the item-level distribution suggests predominantly positive beliefs toward medication and relatively low levels of intentional or attitudinal non-adherence.

Bivariate analysis did not demonstrate any statistically significant association between medication adherence and the examined sociodemographic or clinical variables as depicted in Table III and Table IV respectively. Good adherence was observed across both age groups (<60 years: 90.1% vs ≥60 years: 87.5%; p=0.438) and between males (88.2%) and females (90.1%; p=0.545). Similarly, adherence did not significantly differ across socioeconomic categories (p=0.800) or educational levels (p=0.775). Current occupational status (p=0.325), religion (p=0.145), caste (p=0.492), type of family (p=0.679), marital status (p=0.348), and residence status (p=0.492) were also not significantly associated with medication adherence. Therefore, medication adherence scores did not significantly differ across age groups, gender, educational status, or socioeconomic categories.

Figure 2 illustrates the distribution of medication adherence across disease categories. Among participants with Hypertension alone, 86.6% demonstrated high adherence and 23 (13.4%) had low adherence. Similarly, among individuals with Diabetes alone, 109 (90.1%) showed high adherence while 12 (9.9%) were poorly adherent. Among those with both Diabetes and Hypertension, 99 (92.5%) exhibited high adherence and 8 (7.5%) had low adherence. Overall, high adherence was consistently observed across all disease categories. As depicted in Table IV, adherence did not vary significantly by the clinical factors such as disease category (Diabetes, Hypertension, or both; p=0.284), number of medicines taken (monotherapy or polytherapy, p=0.462), BMI classification (p=0.418), or adequacy of sleep duration (p=0.122). There was no statistically significant difference in the duration since diagnosis of Hypertension (Mann-Whitney U = 4586, p = 0.790) or Diabetes (Mann-Whitney U = 2054, p = 0.958) between participants with good and poor medication adherence. Overall, medication adherence appeared to be uniformly distributed across sociodemographic and clinical strata in the study population and not independently associated with adherence levels.

Table I: Sociodemographic Characteristics of Adults with Diabetes and/or Hypertension in South Andaman (N = 400)
Sociodemographic factors Male n (%) Female n (%) Frequency (%)
Age in years Less than 60 115 (42.3) 157 (57.7) 272 (100)
More than 60 63 (49.2) 65 (50.8) 128 (100)
Education No formal education 44 (33.8) 86 (66.2) 130 (100)
Primary education 27 (40.3) 40 (59.7) 67 (100)
Secondary education 77 (52.0) 71 (48.0) 148 (100)
Higher education 30 (54.5) 25 (45.5) 55 (100)
Occupation Elementary occupation 40 (71.4) 16 (28.6) 56 (100)
Plant and machine operators and assemblers 10 (83.3) 2 (16.7) 12 (100)
Craft and related trade workers 11 (64.7) 6 (35.3) 17 (100)
Skilled agricultural and fishery workers 11 (91.7) 1 (8.3) 12 (100)
Skilled workers and shop and market sales workers 30 (76.9) 9 (23.1) 39 (100)
Clerks 12 (57.1) 9 (42.9) 21 (100)
Technicians and associate professionals 4 (50.0) 4 (50.0) 8 (100)
Professionals 5 (41.7) 7 (58.3) 12 (100)
Unemployed/ retired 55 (24.7) 168 (75.3) 223 (100)
Socioeconomic status Upper 19 (54.3) 16 (45.7) 35 (100)
Upper Middle 28 (54.9) 23 (45.1) 51 (100)
Lower Middle 34 (54.8) 28 (45.2) 62 (100)
Upper Lower 82 (41.8) 114 (58.1) 196 (100)
Lower 15 (26.8) 41 (73.2) 56 (100)
Religion Hindu 135 (46.2) 157 (53.8) 292 (100)
Muslim 32 (41.6) 45 (58.4) 77 (100)
Christian 11 (35.5) 20 (64.5) 31 (100)
Caste General 140 (45.3) 169 (54.7) 309 (100)
Others 38 (41.8) 53 (58.2) 91 (100)
Type of family Nuclear 104 (49.8) 105 (50.2) 209 (100)
Joint 60 (38.0) 98 (62.0) 158 (100)
Extended 14 (42.4) 19 (57.6) 33 (100)
Marital status Married 169 (47.6) 186 (52.4) 355 (100)
Unmarried 0 (0) 2 (100.0) 2 (100)
Widowed 34 (79.1) 9 (20.9) 43 (100)
Resident status Native island resident 163 (43.2) 214 (56.8) 377 (100)
Non-native resident 15 (65.2) 8 (34.8) 23 (100)
Table II: Clinical characteristics of Adults with Diabetes and/or Hypertension in South Andaman (N = 400)
Clinical parameters Mean (Standard Deviation)
Duration since diagnosis (in years) Diabetes 6.62 (5.98)
Hypertension 6.66 (5.83)
Number of medicines taken Diabetes 1.64 (0.73)
Hypertension 2.22 (1.50)
Body Mass Index(Asian classification) Diabetes 25.54 (3.76)
Hypertension 25.54 (3.76)
Number of hours of sleep Diabetes 6.59 (1.34)
Hypertension 6.59 (1.34)
Figure
Figure 1: Components of medication adherence (N=400)
Table III: Association between Sociodemographic Characteristics and Medication Adherence
Sociodemographic factors Medication Adherence f (%) Chi-square/ Fischer Exact test P value
Good Poor
Age Less than 60 years 245 (90.1) 27 (9.9) 0.601 0.438
More than 60 years 112 (87.5) 16 (12.5)
Gender Male 157 (88.2) 21 (11.8) 0.367 0.545
Female 200 (90.1) 22 (9.9)
Socioeconomic status Upper 32 (91.4) 3 (8.6) 0.445 0.800
Middle 102 (90.3) 11 (9.7)
Lower 223 (88.5) 29 (11.5)
Education No formal education 116 (89.2) 14 (10.8) 1.109 0.775
Primary education 61 (91.0) 6 (9.0)
Secondary education 133 (89.9) 15 (10.1)
Higher education 47 (85.5) 8 (14.5)
Current occupational status Not working 196 (87.9) 27 (12.1) 0.968 0.325
Working 161 (87.9) 16 (9.0)
Religion Hindu 260 (89.0) 32 (11.0) 3.860 0.145
Muslim 72 (93.5) 5 (6.5)
Christian 25 (80.6) 6 (19.4)
Caste General 274 (88.7) 35 (11.3) 0.471 0.492
Others 83 (91.2) 8 (8.8)
Type of family Nuclear 188 (90.0) 21 (10.0) 0.774 0.679
Joint 141 (89.2) 17 (10.8)
Extended 28 (84.8) 5 (15.2)
Marital status Married 315 (88.7) 40 (11.3) 0.881 0.348
Others 42 (93.3) 3 (6.7)
Residence Islander 335 (88.9) 42 (11.1) *1.994 0.492
Mainland India 22 (95.7) 1 (4.3)
Table IV: Association between Clinical Characteristics and Medication Adherence
Clinical factors Medication Adherence f (%) Chi-square/ Fischer Exact test P value
Good Poor
Chronic diseases Diabetes 109 (90.1) 12 (9.9) 2.515 0.284
Hypertension 149 (86.6) 23 (13.4)
Both 99 (92.5) 8 (7.5)
Number of medicines taken Monotherapy 236 (90.1) 26 (9.9) 0.540 0.462
Polytherapy 121 (87.7) 17 (12.3)
BMI Normal 78 (90.7) 8 (9.3) 2.832 0.418
Underweight 9 (75.0) 3 (25.0)
Overweight 69 (88.5) 9 (11.5)
Obese 201 (89.7) 23 (10.3)
Number of hours of sleep Adequate 202 (91.4) 19 (8.6) 2.385 0.122
Inadequate 155 (86.6) 24 (13.4)
Figure
Figure 2: Medication adherence among individuals with Diabetes and/or Hypertension (N=400)

Discussion

The present study assessed medication adherence among adults with Diabetes and/or Hypertension in South Andaman using the MARS-10 scale and explored its association with sociodemographic and clinical characteristics. The mean adherence score was 7.74 (1.42), and nearly nine out of ten participants (89.3%) demonstrated good adherence. Importantly, medication adherence did not show statistically significant associations with age, gender, education, socioeconomic status, religion, caste, marital status, residence status, occupational status, disease category, BMI, duration of illness, number of medications, or sleep duration. These findings suggest that adherence behavior in this population is relatively homogeneous and not strongly patterned by conventional sociodemographic or clinical determinants.

The proportion of good medication adherence observed in the present study (89.3%) is substantially higher than that reported in many mainland Indian and international studies [12]. A study from Cameroon documented a non-adherence prevalence of 54.4% (95% CI: 47.1–61.5%) and identified older age, alcohol consumption, and insulin-only therapy as independent predictors of non-adherence [13]. Among hypertensive populations, lower adherence levels have also been reported; a study from Saudi Arabia found that only 36.3% of participants demonstrated high adherence, while 63.7% had low or moderate adherence, and a study from Nepal reported a prevalence of high adherence of 61% [14,15]. Despite geographical constraints and potential access barriers, the findings may indicate strong health-seeking behaviour and adherence to medical advice among island residents, possibly driven by a desire to preserve functional independence and prevent NCD-related complications.

High medication adherence could also be attributed to contextual factors unique to South Andaman including relatively smaller and stable population structure and better continuity of care in a geographically bounded setting. The item-wise analysis of MARS-10 further supports this observation. The majority of participants endorsed positive beliefs regarding medication use, with over 95% agreeing that staying on medication prevents illness and that their thoughts are clearer while on medication. Intentional non-adherence behaviors such as stopping medication when feeling better (12.0%) or worse (3.8%) were relatively uncommon. This pattern suggests that non-adherence in this setting may be driven more by unintentional factors (e.g., forgetfulness reported by 35%) rather than negative beliefs about medication. Additionally, the high proportion of married individuals (88.8%) and predominance of nuclear or joint family structures may contribute to consistent social support across groups, attenuating variability in adherence behavior.

The study did not find significant associations between adherence and disease type (Diabetes, Hypertension, or both), duration of illness, number of medications, BMI, or sleep duration. This is particularly important, as polypharmacy and longer disease duration are often linked with poorer adherence in chronic disease populations [16]. The relatively low pill burden (1.64 for Diabetes and 2.22 for Hypertension) may partly explain the sustained adherence levels. Furthermore, the absence of association between duration of illness and adherence (as assessed by Mann-–Whitney U test) suggests that treatment fatigue may not be a major concern in this setting.

The use of the MARS-10, a validated and widely used tool, ensured standardized and reliable measurement of medication adherence across participants. A robust sample size for a geographically isolated setting like South Andaman and the facility-based recruitment ensured that all participants were confirmed diagnosed cases actively receiving treatment, adding clinical relevance to the findings. Notably, this study addresses a significant evidence gap, being the first to examine medication adherence in this underrepresented region.

Nonetheless, certain methodological considerations warrant caution while interpreting the findings. The cross-sectional design limits any causal interpretation and does not allow for assessment of adherence patterns over time. The facility-based approach may not fully capture individuals managing these conditions outside the formal healthcare system, potentially skewing adherence estimates upward. Self-reported data, while practical, carries the inherent risk of social desirability bias, and consecutive sampling may restrict the broader generalizability of the results. Since 35% of participants reported occasionally forgetting medication, simple and low-cost interventions such as medication reminders, structured follow-up calls, SMS reminders, pill organizers or family engagement strategies could meaningfully improve adherence at the facility level. Healthcare providers should routinely screen for unintentional non-adherence rather than assuming that positive medication beliefs translate into consistent behaviour.

Declarations

Ethical Clearance

Ethical clearance for this study was obtained from the Institutional Ethics Committee of Andaman and Nicobar Islands Institute of Medical Sciences, vide reference number ANIIMS/IEC.2025/29, dated 09/03/2025. Written informed consent was obtained from all participants prior to data collection, and confidentiality of participant information was maintained throughout the study.

Conflict of interest declaration

The authors declare no conflict of interest in relation to this study.

Funding/ financial support

This research received no specific funding from any public, commercial, or not-for-profit funding agency. The study was conducted as part of the authors' academic work and was self-funded.

Contributors

The authors acknowledge the contribution of medical officers and staff of the health centres in South Andaman for their administrative support and all participants for their willing participation in the study.

Contribution details

Gayathri Ponath Sukumaran - concept, design, definition of intellectual content, manuscript editing and manuscript review- guarantor

Aanchal Anand - data analysis, manuscript preparation, manuscript editing and manuscript review

Samar Hossain - concept, design, definition of intellectual content, manuscript editing and manuscript review

Ajay Raj Sethuraman - literature search, data acquisition, data analysis, manuscript preparation

Acknowledgements

None

Section

References
  1. Noncommunicable diseases [Internet]. Geneva, Switzerland: World Health Organisation; [cited 2026 Feb 20]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
  2. Diabetes [Internet]. World Health Organization; [cited 2026 Jan 19]. Available from: https://www.who.int/health-topics/diabetes
  3. Facts & figures. International Diabetes Federation [Internet]. [cited 2026 Feb 20]. Available from: https://idf.org/about-diabetes/diabetes-facts-figures/
  4. Hypertension [Internet]. World Health Organization; [cited 2026 Feb 24]. Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension
  5. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005 Jun;43(6):521-30. doi: . 86870.af PubMed PMID: 15908846. DOI: 10.1097/01.mlr.0000163641
  6. Olickal JJ, Chinnakali P, Suryanarayana BS, Saya GK, Ganapathy K, Subrahmanyam DKS. Medication adherence and glycemic control status among people with diabetes seeking care from a tertiary care teaching hospital, south India. Clinical Epidemiology and Global Health. 2021 Jul 1;11. doi: DOI: 10.1016/j.cegh.2021.100742
  7. Chan AHY, Horne R, Hankins M, Chisari C. The Medication Adherence Report Scale: A measurement tool for eliciting patients’ reports of nonadherence. Br J Clin Pharmacol. 2020 Jul;86(7):1281–8. doi: PubMed PMID: 31823381; PubMed Central PMCID: PMC7319010. DOI: 10.1111/bcp.14193
  8. Ross B, Wang D, Xi C, Pan Y, Zhou L, Yang X, et al. Medication adherence and its correlates among patients with recurrent schizophrenia: a large-scale study in China. Schizophr Bull. 2020 May;46(Suppl 1):S315. doi: PubMed PMID: null; PubMed Central PMCID: PMC7234590. DOI: 10.1093/schbul/sbaa029.777
  9. Mandal I, Hossain SR. Modified Kuppuswamy scale updated for the year 2025. Int J Community Med Public Health. 2025 May;12(5):2423–5. doi: DOI: 10.18203/2394-6040.ijcmph20251411
  10. Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009 Feb;57:163–70. PubMed PMID: 19582986.
  11. Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, et al. Recommended Amount of Sleep for a Healthy Adult: A Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society. Sleep. 2015 Jun 1;38(6):843–4. doi: PubMed PMID: 26039963; PubMed Central PMCID: PMC4434546. DOI: 10.5665/sleep.4716
  12. Wibowo MINA, Yasin NM, Kristina SA, Prabandari YS. A systematic review on self-reported questionnaires to assess medication adherence in diabetic patients. Malaysian Journal of Public Health Medicine. 2021 Aug 28;21(2):359–73. doi: DOI: 10.37268/mjphm/vol.21/no.2/art.1048
  13. Aminde LN, Tindong M, Ngwasiri CA, Aminde JA, Njim T, Fondong AA, et al. Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. BMC Endocr Disord. 2019 Apr 3;19(1):35. doi: DOI: 10.1186/s12902-019-0360-9
  14. Thirunavukkarasu A, Naser Abdullah Alshahrani A, Mazen Abdel-Salam D, Homoud Al-Hazmi A, Farhan ALruwaili B, Awad Alsaidan A, et al. Medication Adherence Among Hypertensive Patients Attending Different Primary Health Centers in Abha, Saudi Arabia: A Cross-Sectional Study. Patient Prefer Adherence. 2022 Oct 19; 16:2835–44. doi: PubMed PMID: 36303595; PubMed Central PMCID: PMC9592733. DOI: 10.2147/PPA.S388365
  15. Sharma S, Sharma CR, Sharma S, Aryal S, Bhandari B. Adherence to antihypertensive medication and its associated factors among patients with hypertension attending a tertiary hospital in Kathmandu, Nepal. PLOS ONE. 2024 Jul 3;19(7):e0305941. doi: DOI: 10.1371/journal.pone.0305941
  16. Shankar G K, Kannan L. Medication Adherence Among Diabetic and Hypertensive Patients in Rural Tamil Nadu: A Cross-Sectional Study. Cureus [Internet]. 2025 Aug 25 [cited 2026 Feb 19];17(8). Available from: https://www.cureus.com/articles/405628-medication-adherence-among-diabetic-and-hypertensive-patients-in-rural-tamil-nadu-a-cross-sectional-study#!/
Author Resources